Arteriocyte Medical Systems

company

About

Arteriocyte Medical Systems is a medical device company developing innovative solutions to improve the outcomes of surgical procedures.

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$509K
Industries
Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

Arteriocyte Medical Systems, Inc. is a leading medical device company dedicated to helping patients heal faster by developing innovative solutions to improve the outcomes of surgical procedures based on cell and tissue based therapies.

The Company’s lead product is the Magellan® Autologous Platelet Separator. The Magellan® System provides surgeons the ability to fractionate peripheral blood and/or aspirated bone marrow from a patient, for that patient, at bedside in approximately 15 minutes using a fully automated closed loop separation process. The Magellan® device yields a 3-10cc injectable unit of platelet and stem cell enriched plasma for the surgeon’s use in his or her procedure.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$509K
Arteriocyte Medical Systems has raised a total of $509K in funding over 2 rounds. Their latest funding was raised on Jan 15, 2008 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 15, 2008 Grant $509K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Arteriocyte Medical Systems is funded by 1 investors. Global Cardiovascular Innovation Center are the most recent investors.
Investor Name Lead Investor Funding Round
Global Cardiovascular Innovation Center Grant